Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial

Kathryn E. Stephenson, Chen Sabrina Tan, Stephen R. Walsh, Andrew J. Hale, Jessica L. Ansel, Diane G. Kanjilal, Kate Jaegle, Lauren Peter, Erica N. Borducchi, Joseph P. Nkolola, Tatenda Makoni, Rachel Fogel, Connor Bradshaw, Anna L. Tyler, Edward T. Moseley, Abishek Chandrashekar, Katherine E. Yanosick, Michael S. Seaman, Kenneth H. Eckels, Rafael A. De La Barrera, Jason Thompson, Peter Dawson, Stephen J. Thomas, Nelson L. Michael, Kayvon Modjarrad, Dan H. Barouch